Figure 3 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
<p>Differential single-gene expression changes between baseline and surgery of the 17 genes included in the FOS and JUN module scores in the POETIC cohort. Differential expression in the treated samples from POETIC subset (<b>A</b>) and in the controls (<b>B</b>). In re...
محفوظ في:
| المؤلف الرئيسي: | Milana A. Bergamino (15038015) (author) |
|---|---|
| مؤلفون آخرون: | Gabriele Morani (15038018) (author), Joel Parker (15038021) (author), Eugene F. Schuster (9726535) (author), Mariana F. Leal (15038024) (author), Elena López-Knowles (15038027) (author), Holly Tovey (9360536) (author), Judith M. Bliss (8827107) (author), John F.R. Robertson (15025368) (author), Ian E. Smith (1545553) (author), Mitch Dowsett (645) (author), Maggie C.U. Cheang (14946768) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
حسب: Milana A. Bergamino (15038015)
منشور في: (2025) -
Figure 2 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
حسب: Milana A. Bergamino (15038015)
منشور في: (2025) -
Figure 4 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
حسب: Milana A. Bergamino (15038015)
منشور في: (2025) -
Figure 5 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
حسب: Milana A. Bergamino (15038015)
منشور في: (2025) -
Figure 6 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
حسب: Milana A. Bergamino (15038015)
منشور في: (2025)